These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35081302)

  • 21. Game Changer in Acne Treatment.
    Kircik LH
    J Drugs Dermatol; 2020 Mar; 19(3):28. PubMed ID: 32550698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of hormonal agents in the treatment of acne.
    Hassoun LA; Chahal DS; Sivamani RK; Larsen LN
    Semin Cutan Med Surg; 2016 Jun; 35(2):68-73. PubMed ID: 27416311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro.
    Rosette C; Rosette N; Mazzetti A; Moro L; Gerloni M
    J Drugs Dermatol; 2019 Feb; 18(2):197-201. PubMed ID: 30811143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Developments in Topical Acne Therapy.
    Drake L; Reyes-Hadsall S; Barbieri JS; Mostaghimi A
    Am J Clin Dermatol; 2022 Mar; 23(2):125-136. PubMed ID: 35041198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream.
    Sanchez C; Keri J
    Clin Cosmet Investig Dermatol; 2022; 15():1357-1366. PubMed ID: 35874458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris.
    Marks DH; Prasad S; De Souza B; Burns LJ; Senna MM
    Am J Clin Dermatol; 2020 Apr; 21(2):245-254. PubMed ID: 31832993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy.
    Marks DH; Mansh MD
    JAMA Dermatol; 2020 Dec; 156(12):1380-1381. PubMed ID: 33146681
    [No Abstract]   [Full Text] [Related]  

  • 29. Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy-Reply.
    Thiboutot D; Cartwright M; Mazzetti A
    JAMA Dermatol; 2020 Dec; 156(12):1381. PubMed ID: 33146696
    [No Abstract]   [Full Text] [Related]  

  • 30. Clascoterone as a novel treatment for androgenetic alopecia.
    Sun HY; Sebaratnam DF
    Clin Exp Dermatol; 2020 Oct; 45(7):913-914. PubMed ID: 32421862
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of Acne Vulgaris: A Review.
    Eichenfield DZ; Sprague J; Eichenfield LF
    JAMA; 2021 Nov; 326(20):2055-2067. PubMed ID: 34812859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li WA
    Cochrane Database Syst Rev; 2003; (1):CD002086. PubMed ID: 12535427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the Effects of Oral and Topical Simvastatin in the Treatment of Acne Vulgaris: A Double-blind, Randomized, Placebo-controlled Clinical Trial.
    Ahmadvand A; Yazdanfar A; Yasrebifar F; Mohammadi Y; Mahjub R; Mehrpooya M
    Curr Clin Pharmacol; 2018; 13(4):279-283. PubMed ID: 30129417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common and alternate oral antibiotic therapies for acne vulgaris: a review.
    Amin K; Riddle CC; Aires DJ; Schweiger ES
    J Drugs Dermatol; 2007 Sep; 6(9):873-80. PubMed ID: 17941358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li Wan Po A
    Cochrane Database Syst Rev; 2000; (2):CD002086. PubMed ID: 10796856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment.
    Hazarika N
    J Dermatolog Treat; 2021 May; 32(3):277-285. PubMed ID: 31393195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.
    Stotland M; Shalita AR; Kissling RF
    Am J Clin Dermatol; 2009; 10(4):221-7. PubMed ID: 19489655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of the use of combination therapies for the treatment of acne vulgaris.
    Leyden JJ
    J Am Acad Dermatol; 2003 Sep; 49(3 Suppl):S200-10. PubMed ID: 12963896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents.
    de Leeuw J; van der Beek N; Bjerring P; Neumann HA
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):460-9. PubMed ID: 19796088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.